Next Article in Journal / Special Issue
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
Previous Article in Journal
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
Previous Article in Special Issue
Oncolytic Adenoviruses in Cancer Treatment
Article Menu

Export Article

Biomedicines 2014, 2(1), 98-109; doi:10.3390/biomedicines2010098
Open AccessArticle

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 5 March 2014 09:07 CET Version of Record
article pdf uploaded. 6 March 2014 08:15 CET Updated version of record
article html file updated 19 August 2015 22:36 CEST Original file
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top